LaudinoManuelCastillo-RojasMD
Cardiology • Fort Sam Houston, TXAdult Congenital Heart Disease
Physician
Dr. Castillo-Rojas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3851 Roger Brooke Dr
Brooke Army Medical Center - Mche-Qd/Credentials
Fort Sam Houston, TX 78234Phone+1 210-916-2460
Education & Training
San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 2004 - 2007
Ponce Health Sciences University School of MedicineClass of 2004
Certifications & Licensure
IN State Medical License 2005 - 2025
Clinical Trials
- Rosiglitazone And Fenofibrate Additive Effects on Lipids (RAFAEL) Start of enrollment: 2008 Sep 01
Publications & Presentations
PubMed
- 253 citationsSudden death in young adults: an autopsy-based series of a population undergoing active surveillance.Robert E. Eckart, Eric A. Shry, Allen P. Burke, Jennifer A. McNear, David A. Appel
Journal of the American College of Cardiology. 2011-09-13 - 2 citationsThe Effects of Extended Release Niacin in Combination with Omega 3 Fatty Acid Supplements in the Treatment of Elevated Lipoprotein (a).Alan F. Helmbold, Jennifer N. Slim, Jennifer Morgan, Laudino M. Castillo-Rojas, Eric A. Shry
Cholesterol. 2010-02-24 - 2 citationsRosiglitazone and fenofibrate additive effects on lipids.Ahmad M. Slim, Laudino M. Castillo-Rojas, Edward Hulten, Jennifer N. Slim, Dorette Pearce Moore
Cholesterol. 2011-11-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
